Company Overview and News

 
Opcity, Lead Conversion, And The Journey Down The Funnel

2018-09-12 seekingalpha
Last week, News Corp, owner of realtor.com in the U.S. and the majority owner of REA Group in Australia, announced the $210 million acquisition of lead qualification service Opcity.
GJV NWS NWSA RPGRF REA RPGRY

 
Planning changes to spread 'Silicon Yarra' to other suburbs

2018-09-11 theage.com.au
A new Victorian town planning category aims to encourage ‘new economy’ enterprises to inner-city suburbs such as Brunswick, South Melbourne and Collingwood, in the same way they have transformed the once-obscure industrial precinct of Cremorne into an entrepreneurial office hub.
RPGRF REA RPGRY

 
Planning changes to spread 'Silicon Yarra' to other suburbs

2018-09-11 smh.com.au
A new Victorian town planning category aims to encourage ‘new economy’ enterprises to inner-city suburbs such as Brunswick, South Melbourne and Collingwood, in the same way they have transformed the once-obscure industrial precinct of Cremorne into an entrepreneurial office hub.
RPGRF REA RPGRY

 
News Corp.'s Move To Acquire Opcity For Real Estate Lead Gen

2018-09-07 seekingalpha
NWS is smart to double down on its Move subsidiary, with digital real estate being the fastest-growing segment in the company.
GJV NWS NWS NWSA RPGRF REA RPGRY

 
News Corp's Move To Acquire Opcity For Real Estate Lead Gen

2018-09-07 seekingalpha
NWS is smart to double down on its Move subsidiary, with digital real estate being the fastest-growing segment in the company.
GJV NWS NWS NWSA RPGRF REA RPGRY

 
CBD: King-sized field to replace Turnbull in Wentworth

2018-09-05 smh.com.au
There’s a new twist to the crowded field to replace Malcolm Turnbull as the Liberal candidate for the bluer-than-blue ribbon seat of Wentworth.
GJV NWS NWSA RPGRF REA RPGRY

16
Australia’s Silicon Valley: Next big tech firm joins who’s who at Silicon Yarra

2018-09-05 perthnow.com.au
A precinct of inner Melbourne has cemented its status as Australia’s Silicon Valley, luring yet another tech titan, writes Claire Heaney.
RPGRF REA RPGRY DIS

16
‘Silicon Yarra’ snares new tech titan

2018-09-05 ntnews.com.au
A precinct of inner Melbourne has cemented its status as Australia’s Silicon Valley, luring yet another tech titan , writes Claire Heaney.
RPGRF REA RPGRY DIS

9
News Corp Inks Deal with Opcity to Boost Digital Offerings

2018-08-30 zacks
News Corporation’s (NWSA - Free Report) fully-owned subsidiary Move, Inc. (operator of realton.com) has inked a deal to acquire real-estate technology platform Opcity for $210 million in a bid to grow its presence in the digital real-estate market. With this deal, realtor.com will be able to expand its lead generation product portfolio by introducing the option of availing a concierge-based model that offers thoroughly-researched, transaction-ready leads to real-estate professionals.
GJV TGT NWS NWSA SCVL RPGRF REA URBN TECD RPGRY BOOT

 
The Wall Street Journal: News Corp to acquire online real-estate platform Opcity for $210 million

2018-08-29 marketwatch
News Corp’s subsidiary Move Inc., operator of Realtor.com, has agreed to acquire real-estate technology platform Opcity for $210 million, as the media and information services company looks to increase its presence in the digital real-estate services market.
GJV NWS NWSA RPGRF REA RPGRY

 
The ‘Gong boy’ who ran Google Australia: Jason Pellegrino

2018-08-26 theage.com.au
When Jason Pellegrino told his children that he’d landed a new job running property website Domain, he didn’t get the reaction he’d hoped for. Rather than offering congratulations, young Alex, Harry, Lily and Mia asked: “Why are you trying to sell couches?”
GJV BLT NWSA NWS BHP BHPBF RPGRF BBL REA BHP BHPLF RPGRY

 
The ‘Gong boy’ who ran Google Australia: Jason Pellegrino

2018-08-26 smh.com.au
When Jason Pellegrino told his children that he’d landed a new job running property website Domain, he didn’t get the reaction he’d hoped for. Rather than offering congratulations, young Alex, Harry, Lily and Mia asked: “Why are you trying to sell couches?”
GJV BLT NWSA NWS BHP BHPBF RPGRF BBL REA BHP BHPLF RPGRY

 
Labor attacks NBN CEO appointment amid Coalition leadership turmoil

2018-08-22 theage.com.au
The Turnbull government has been forced to defend the appointment of Stephen Rue as the new chief executive of the National Broadband Network, amid fresh Coalition leadership turmoil in Canberra.
GJV NWS NWSA RPGRF REA RPGRY

 
Labor attacks NBN CEO appointment amid Coalition leadership turmoil

2018-08-22 smh.com.au
The Turnbull government has been forced to defend the appointment of Stephen Rue as the new chief executive of the National Broadband Network, amid fresh Coalition leadership turmoil in Canberra.
GJV NWS NWSA RPGRF REA RPGRY

 
Fresh stock was on way just as REA Group boss dumped her shares

2018-08-21 theage.com.au
It is pretty rare to see a CEO dump almost their entire shareholding in their company for no particular reason, so you can imagine the speculation when news dropped on Monday evening that REA Group boss Tracey Fellows sold off 10,206 shares which left her with just 12 shares to her name.
GJV NWS NWSA RPGRF REA MOC RPGRY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 023597632